Health ❯ Medical Research

Cancer Treatment

Immunotherapy Drug Development Innovative Therapies Radiation Therapy Nanotechnology Leukemia Pancreatic Cancer Targeted Therapy Therapeutics mRNA Therapy mRNA Vaccines Vaccine Development Autoimmune Diseases Therapies Pharmaceuticals mRNA Technology Therapeutic Targets Multiple Myeloma Artificial Intelligence in Medicine Nanomedicine Chemotherapy Optimization Alzheimer's Research Vaccination Pharmacology Targeted Alpha Therapy Patient Outcomes Microbial Therapy Radiation Studies DNA Damage Radiopharmaceuticals Microbiology Innovations Therapeutic Approaches Oncolytic Virus Therapy Infectious Diseases Oncolytic Viruses Chemotherapy Resistance Melanoma Combination Therapy Genetic Research Cancer Drugs Bladder Cancer Biotechnology Brain Cancer LED Therapy Chemotherapy Chemotherapy Effects Radioisotopes Vitamin C Drug Delivery Radioligand Therapy Personalized Medicine Microgravity Effects Hope in Healthcare Bacterial Therapy Early Detection Kidney Cancer Federal Funding Blood Tests Genetic Engineering Lymphoma Studies Aging Research Genetic Diagnostics Predictive Tools Oncology Cell Therapy Survival Rates Surgery Techniques Nanoparticles Grant Funding FDA Approvals Space Medicine Aspirin Research AI in Medicine Photonics AI in Healthcare Precision Medicine Tumor Microenvironment Vaccines Gene Therapy Protein Function in Disease CAR T Cell Therapy CAR-T Cell Therapy Antitumor Immunity

Moderna and Merck Report Promising Phase III Results for Personalized mRNA Melanoma Vaccine

If confirmed by full peer review and regulators this result could open the way for individualized mRNA shots to reduce melanoma recurrence.

Stories older than 24h

Algae-Based Microrobots Greatly Increase Chemotherapy Delivery to Bladder Tumors

Researchers Find 14‑Protein Blood Signature That Predicts Lung Cancer Years Ahead

White House Rule Would Put Political Appointees in Charge of Federal Grants

CRISPR Enzyme Cas12a2 Selectively Destroys Cells Based on RNA in Lab Tests

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

New Study Explains Why BET Drugs Falter by Splitting BRD2 and BRD4 Roles

TerraPower Isotopes Chooses Philadelphia's Bellwether District for $450 Million Actinium-225 Plant

Waterloo Scientists Ready Engineered Tumor‑Eating Bacteria for Preclinical Testing

New Single-Particle Assay Finds Disordered Lipid Nanoparticles Release RNA More Effectively

Brookhaven Shuts RHIC After Final Collision as DOE Approves Electron-Ion Collider

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Cypherpunk Lifts Zcash Treasury to 290,062.67 ZEC With $29 Million Buy

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

US Cuts $500 Million in mRNA Vaccine Research Funding

Bacteria-Shielded Virus Platform Clears Tumors in Mice

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Deep-Sea Bacterial Molecule Triggers Pyroptosis to Suppress Tumor Growth